Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 6Other hematologic neoplasm 4Thoracic 3Lymphoid 3Other solid neoplasm 2Other 2Genitourinary 2Other neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1CNS 1

Conditions

Dyslipidemias 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Exercise Test × CNS × Clear all
NCT05641636 2022-12-07

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

I.M. Sechenov First Moscow State Medical University

Completed
60 enrolled
CNS

Central Nervous System Neoplasms, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡